US Capital Partners Provides Multi-Million Dollar Financing for Chantilly BioPharma, LLC
US Capital Partners, LLC has structured and put in place custom debt financing for a growing, early-stage Virginia-based specialty pharmaceutical company.
SAN FRANCISCO, AUGUST 2013 – US Capital Partners, LLC has provided expansive term loan financing for Chantilly BioPharma, LLC (“CBL”), headquartered in Chantilly, Virginia. US Capital Partners is a private investment bank that makes direct debt investments, participates in debt facilities, and arranges equity placements for small to lower middle market companies.
“Our company is engaged in the development, manufacturing, commercialization, licensing, and marketing of proprietary technologies and products for a wide range of pharmaceuticals,” said S. Rao Cherukuri, founder and Chairman of CBL. “We have been expanding the business in both the retail and non-retail segments, and needed financing for capital expenditure and to support our growing working capital needs. We approached US Capital Partners for help and are extremely pleased with the result.”
“We are delighted to have provided financing for this Virginia-based specialty pharmaceutical company,” said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. “CBL needed our expertise to structure, underwrite, and provide optimal financing to support its continued business growth. US Capital Partners provided expansive term loan financing for CBL, and expedited the timeline to close upon completion of its appraisal report on the business.”
About Chantilly BioPharma, LLC.
Chantilly BioPharma, LLC (“CBL”) develops, manufactures, and markets generic pharma-ceuticals and controlled substances using oral drug delivery techniques, including taste masking and controlled release platforms. CBL holds over 50 issued and 11 pending US patents and over 100 international patents and applications that cover its unique drug delivery methods. The company has a state-of-the-art facility with up-to-date quality assurance systems for manufacturing, analytical testing, and packaging of prescription products.
About US Capital Partners, LLC
Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing prompt, innovative, and reliable financing solutions including lending, equity financing, and debt re-structuring to businesses across the United States and abroad. US Capital Partners is a private investment bank, direct lender, co-lender, and lead financial arranger that specializes in asset-based debt for small to middle market private and public companies. The company’s innovative approach allows it to provide the best financing available, not only for companies in excellent financial condition, but also for companies that may have been refused credit by traditional lenders.
To learn more about how your business can secure the funding it needs, email Jeffrey Sweeney, CEO and Managing Director, at firstname.lastname@example.org or call (415) 889-1010.